ALBERT DAVID
Back to Income Statement
|
ALBERT DAVID Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹334 Cr | ₹346 Cr | ₹362 Cr | ₹342 Cr | ₹314 Cr |
What is the latest Revenue of ALBERT DAVID ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹334 Cr |
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹362 Cr |
| Mar2023 | ₹342 Cr |
| Mar2022 | ₹314 Cr |
How is Revenue of ALBERT DAVID Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹334 Cr | -3.52 | |
| Mar2025 | ₹346 Cr | -4.61 | |
| Mar2024 | ₹362 Cr | 6.12 | |
| Mar2023 | ₹342 Cr | 8.95 | |
| Mar2022 | ₹314 Cr | - | |
Compare Revenue of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹443.3 Cr | 2% | -6.4% | -5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 2% |
-6.4% |
-5.5% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses